Moderna buys biomanufacturing plant in Massachusetts; project expected to cost $322M

Moderna has purchased a new biomanufacturing facility in Marlborough, Mass., which will be designated for mRNA manufacturing. It is anticipated to open in September 2024, according to an April 28 report from the Worcester Business Journal

Advertisement

Construction to build-out an additional 60,000 square feet onto the already 140,000-square-foot facility will begin in June 2024 and is projected to cost north of $322 million, the news outlet reported. 

Once construction is complete, the facility will also include a manufacturing clean room, quality control lab space, a satellite warehouse and offices, the Business Journal reported.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.